Phase 1 Safety Study of ALK-001 in Healthy Volunteers

NCT02230228 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt Disease
Age-related Macular Degeneration
Other Retinal Dystrophies

Interventions

DRUG: ALK-001 (No generic name)

Sponsor

Alkeus Pharmaceuticals, Inc.